Free shipping on orders over $99*

Tel: 1-866-456-3768  Fax: 1-866-544-8993

Shipping and Customer Support will be limited Oct 16 -26 due to Jewish holidays.

  • US Name:

    Compounded Tirzepatide

  • Alternative Names:

    Mounjaro, Zepbound

  • Active Ingredients:

    Tirzepatide

  • Brand Manufacturer:

    Lilly

  • Manufacturer Location:

  • Click here to view Product Insert

  • Click here to view Product Insert

  • Click here to view Product Insert

Compounded Tirzepatide *

Prescription Required
All third-party products, company names, and logos are trademarks™ or registered® trademarks are and remain the property of their respective holders. Their use does not imply any affiliation with or endorsement by them. All references on this site to third-party trademarks are intended to constitute nominative fair use under applicable trademark laws.

Mounjaro can be prescribed for glycemic control of adult patients with type 2 diabetes. 

We supply a compounded version of Mounjaro (Tirzepatide).

Please note that this medication is custom compounded for each patient, and it can take 7-10 days for the medication to be prepared and shipped.  Each order comes with the vial of medication and the needles required for injection under the skin.

Currently, we can ship Compounded Tirzepatide to the following states: Alaska, Florida, Georgia, Idaho, Indiana, Iowa, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Texas, Utah, Virginia, West Virginia.

Place your order

Tirzepatide (50mg) Generic 10mg/mL
5 mL Vial
-
+
Our price:
$1,100.00
Tirzepatide (30mg) Generic 10mg/mL
3 mL Vial
-
+
Our price:
$700.00
Tirzepatide (20mg) Generic 10mg/mL
2 mL Vial
-
+
Our price:
$475.00
Tirzepatide (10mg) Generic 10mg/mL
1 mL Vial
-
+
Our price:
$350.00

*Please note all prices are in US dollars

Brand-name Mounjaro (tirzepatide), manufactured by Eli Lilly and Company, is available from IsraelPharm.  We can also supply a compounded version of tirzepatide or the alternative (semaglutide). Both require a healthcare provider’s prescription. Click here to learn more about compounded medications.

Mounjaro is an injectable prescription medicine that is used to treat adults with type 2 diabetes. It is prescribed along with diet and exercise to improve control of blood sugar levels. Mounjaro can be used as a single therapy or with other diabetes medicines. Tirzepatide, marketed as the brand Zepbound, has been approved by the FDA as a weight-loss medication for patients who are overweight (BMI between 27 and 29.9 with at least one weight-related comorbid condition, such as dyslipidemia, hypertension, obstructive sleep apnea, diabetes, or cardiovascular disease) and patients who are obese (BMI higher than 30).

Tirzepatide acts in much the same way as semaglutide, which is the generic component in Ozempic (a weekly injection) and Rybelsus (a daily oral medication), which are approved treatments for diabetes, and Wegovy, which is approved for weight-loss.

Tirzepatide supplies single molecule dual glucagon-like peptide-1 (GLP-1) receptor agonist plus glucose-dependent insulinotropic polypeptide (GIP). Semaglutide supplies only GLP-1. Tirzepatide activates the secretion of GIP and GLP-1 receptors in the gut when glucose or nutrients are eaten. These stimulate the secretion of insulin from the pancreas. They can also regulate food intake control centers in the brain.

These drugs also produce substantial benefits in sustainable weight reduction. In January 2024, the manufacturer of Mounjaro released Zepbound, a drug based on tirzepatide and approved by the FDA for the treatment of obesity. Currently, Saxeanda, Zepbound and Wegovy are approved by the FDA for weight loss.

Tirzepatide is not for use in people with type 1 diabetes.

Dosage

Tirzepatide should be injected subcutaneously once each week on the same weekday at about the same time of the day. Do not use the same site for each injection, but administer in rotation weekly in the abdomen, thigh, or upper arm.

If taking insulin and Tirzepatide simultaneously, do not inject them mixed together in the same injection. You can administer injections of Tirzepatide and insulin in the same body area, but not right next to each other.

This text is for informational purposes only. Please consult with a doctor or pharmacist before using any medication.

Some of the most common side effects of tirzepatide are nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and abdominal pain. If these persist or get worse, seek prompt medical attention.

Please note that not all possible side effects can be listed. 

Warnings

In animal studies, it has been found that GIP/GLP-1RAs and similar drugs may cause thyroid tumors, including thyroid cancer. If there are any symptoms like a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath, these may be symptoms of thyroid cancer. 

People who have any personal or family history of medullary thyroid carcinoma (MTC), or who have the endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not be taking Tirzepatide.

Less frequently, Tirzepatide may cause serious side effects, including:

  • Pancreatitis, caused by inflammation of the pancreas, which can cause severe pain in the stomach area that will not go away, possibly along with vomiting. Pain may spread from the abdomen to the back. If these symptoms present, stop using Tirzepatide and call for support right away.
  • Low blood sugar (hypoglycemia) is possible if Tirzepatide is being used along with another medicine that can reduce blood sugar levels, such as sulfonylurea or insulin. Signs of low blood sugar can include dizziness or light-headedness; sweating; confusion or drowsiness; headache; blurred vision; slurred speech; shakiness; accelerated heartbeat; anxiety, irritability or mood changes; hunger; weakness; or jitters. If these symptoms occur, go to an emergency healthcare facility immediately and tell them what medications you have taken.
  • Tirzepatide can cause a serious allergic reaction, such as swelling of the face, lips, tongue or throat; problems breathing or swallowing; severe rash or itching;, fainting or feeling dizzy; or very rapid heartbeat. Get medical help right away if any of these symptoms appear.
  • Some gallbladder problems have occurred. Report to the healthcare provider immediately if there are symptoms of gallbladder problems, such as pain in the upper abdomen, fever, jaundice (yellowing of skin or eyes), or clay-colored stools.

Tirzepatide can be prescribed to treat adults with type 2 diabetes . It is not suitable for type 1 diabetes, and has not yet been approved for children under the age of 16.

The drug can lower blood sugar levels, but is not a cure for diabetes. Benefits may only begin to show after the first month. Do not stop taking Mounjaro without talking to a doctor.

Treatment with GIP/GLP-1RAs produces significant reductions in the key measurement of blood sugar level, the hemoglobin HbA1c test. This test measures average blood sugar levels over a three-month period. In trials, patients receiving Tirzepatide reached an HbA1c of less than 7 percent, when the average starting HbA1c was between 7.9% and 8.6%. An HbA1c in a normal reading is below 5.7 percent, and diabetes is diagnosed when HbA1c reaches 6.5 percent or above.

Tirzepatide is approved for weight loss along with a calorie-controlled diet and moderate exercise.

  • What should be done if a dose of Tirzepatide is missed?
    A missed dose should be taken as soon as it’s remembered, but not more than four days after it was missed. If more than four days have passed, the missed dose should be skipped completely, with the regular dosing schedule continuing on the next due date. Two doses should not be injected within three days of each other.
  • What should be done in case of overdose of Mounjaro?
    In the case of overdose of Mounjaro (Tirzepatide) call emergency services or take the person straight to the closest emergency room if help can’t be reached quickly. Symptoms of an overdose could resemble hypoglycemia.
  • What foods should be avoided while taking a GLP-1 medication?
    Fried and fatty foods can cause nausea while taking medications like Tirzepatide that contain GLP-1 agonist. Avoiding fast food and limiting foods with high sugar content is usually advised.
  • Can Tirzepatide produce weight loss?
    Tirzepatide is very effective in aiding weight loss. Tirzepatide works in several ways to both control blood sugar levels and promote weight loss. The molecule slows down the emptying of the stomach and inhibits signals of hunger in the brain, both of which act to suppress appetite. This can make people feel satiated for longer, reducing food intake. The FDA now approves Tirzepatide as a weight loss drug, marketed under the brand name Zepbound. Clinical trials lasting 72 weeks of tirzepatide, along with diet and exercise, proved its efficacy and safety for body weight reduction.
  • How has the efficacy of Tirzepatide been proven?
    Several clinical trials in which subjects received Tirzepatide have been peer reviewed and the results generally surpass trials of similar GLP-1 (glucagon like peptide-1 receptor agonist) options. Owing to the unique formula of GIP and GLP-1 receptors, Tirzepatide, compared to other options in clinical trials, produced better results for controlling type 2 diabetes and body weight reduction.

Getting started with IsraelPharm

Required

Send Your Prescription

Secure Payment

No Hidden Fees

Fast Shipping

Generally 7-10 Business Days

Fast delivery
Secure payment
Genuine brands
Pharmacist oversight
Proudly Israeli

Ordering is
simple and safe.

IsraelPharm has been delivering lost cost prescriptions from Israel for over 15 years worldwide. Daily flights allow us to get your medications dispatched fast! Delivery to the USA is under 10 days and you can track and trace every order.

Read more from our blog

Login

Fast Delivery
Ships from Israel
Secure Payment
Genuine Brands
Pharmacist Oversight
Proudly Israeli
Free Shipping on orders over $99*

Having issues?

Daily from 9am-8pm EST.
IsraelPharm c/o SUBS Ltd. Ha'Uman 5 Bet Shemesh Israel, 9906105

Sign up for $10 off your first order!

Enjoy exclusive deals we only share via email